CEVEC closes growth financing round
CEVEC Pharmaceuticals (CEVEC), a provider of high-performance cell technology for scalable manufacturing of advanced bio-therapeutics, has closed an internal growth financing round. Being profitable in 2020, the company plans to use the funds to accelerate company growth and to further build up cell line development capacities to address the growing